Testosterone deficiency

American Journal of Medicine

Volumn 124, Issue 7, 2011, Pages 578-587

  Traish, Abdulmaged M ^a,b   Miner, Martin M ^b,e   Morgentaler, Abraham ^b,c   Zitzmann, Michael ^b,d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d INST OF REPRO MED OF THE UNIV   (Germany)

^e BROWN UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Erectile dysfunction; Insulin resistance; Metabolic syndrome; Testosterone

Indexed keywords

ANDRION; ANDROXON; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTATE SPECIFIC ANTIGEN; RESTINSOL; SUTANON; TESTOPEL; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNDERSTOR;

ANDROGEN DEFICIENCY; ANDROGEN DEFICIENCY; ENANTATE CIPIONATE; ANDROGEN DEFICIENCY; UNDECANOATE CIPIONATE; ANDROGEN DEFICIENCY; UNDECANOATE ENANTATE; BEDTIME DOSAGE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CANCER RISK; CARDIOVASCULAR RISK; CLASSIFICATION ALGORITHM; CLINICAL TRIAL (TOPIC); COMORBIDITY; CONTACT DERMATITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG FORMULATION; ERECTILE DYSFUNCTION; GINGIVA DISEASE; GROUPS BY AGE; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOGONADISM; LIBIDO DISORDER; MALE SEXUAL DYSFUNCTION; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MORTALITY; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TESTOSTERONE BLOOD LEVEL; TRANSDERMAL PATCH; UNSPECIFIED SIDE EFFECT; WAIST CIRCUMFERENCE;

ALGORITHMS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIAGNOSIS, DIFFERENTIAL; ERECTILE DYSFUNCTION; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; INSULIN RESISTANCE; LIBIDO; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROSTATIC NEOPLASMS; RISK FACTORS; TESTOSTERONE;

EID: 79959343414     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.12.027     Document Type: Review

References (112)

1. M.A. Cornier, D. Dabelea, and T.L. Hernandez The metabolic syndrome Endocr Rev 29 2008 777 822
2. C.A. Allan, and R.I. McLachan Age related changes in testosterone and the role of replacement therapy in older men Clin Endocrinol 60 2004 653 670 (Pubitemid 38788071)
3. A. Tajar, G. Forti, T.W. O'Neill European Male Aging Study Group Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Aging Study J Clin Endocrinol Metab 95 2010 1810 1818
4. F.C. Wu, A. Tajar, S.R. Pye European Male Aging Study Group Hypothalamic-pituitary testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study J Clin Endocrinol Metab 93 2008 2737 2745 (Pubitemid 352008544)
5. T. Mulligan, M.F. Frick, Q.C. Zuraw, A. Stemhagen, and C. McWhirter Prevalence of hypogonadism in males aged at least 45 years: the HIM study Int J Clin Pract 60 2006 762 769 (Pubitemid 43881152)
6. M. Zitzmann Testosterone deficiency, insulin resistance and the metabolic syndrome Nat Rev Endocrinol 5 2009 673 681
7. A.B. Araujo, G.R. Esche, and V. Kupelian Prevalence of symptomatic androgen deficiency in men J Clin Endocrinol Metab 92 2007 4241 4247 (Pubitemid 350074738)
8. P. Dandona, and M.T. Rosenberg A practical guide to male hypogonadism in the primary care setting Int J Clin Pract 64 2010 682 696
9. J.M. Kaufman, and A. Vermeulen The decline of androgen levels in elderly men and its clinical and therapeutic implications Endocr Rev 26 2005 833 876 (Pubitemid 41428540)
10. M. Zitzmann, S. Faber, and E. Nieschlag Association of specific symptoms and metabolic risks with serum testosterone in older men J Clin Endocrinol Metab 91 2006 4335 4343 (Pubitemid 44833407)
11. C. Wang, R.S. Swerdloff, and A. Iranmanesh Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men J Clin Endocrinol Metab 85 2000 2839 2853 (Pubitemid 32269162)
12. V. Kupelian, St Page, and A.B. Araujo Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the MetS in non-obese men J Clin Endocrinol Metab 91 2006 843 850 (Pubitemid 43357748)
13. D.E. Laaksonen, L. Niskanen, and K. Punnonen Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men Diabetes Care 27 2004 1036 1041 (Pubitemid 38579762)
14. M. Muller, D.E. Grobbee, I. den Tonkelaar, S.W.J. Lamberts, and Y.T. van der Schouw Endogenous sex hormones and metabolic syndrome in aging men J Clin Endocrinol Metab 90 2005 2618 2623 (Pubitemid 40686299)
15. D.E. Laaksonen, L. Niskanen, and K. Punnonen Sex hormones, inflammation and the metabolic syndrome: a population-based study Eur J Endocrinol 149 2003 601 608 (Pubitemid 38054707)
16. A.E. Heufelder, F. Saad, M.C. Bunck, and L. Gooren Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone J Androl 30 2009 726 733
17. E. Dati, G.I. Baroncelli, and S. Mora Body composition and metabolic profile in women with complete androgen insensitivity syndrome Sex Dev 3 2009 188 193
18. A.E. Sumner The relationship of body fat to metabolic disease: influence of sex and ethnicity Gend Med 5 2008 361 371
19. R.E. Hasson, T.C. Adam, and J.N. Davis Ethnic differences in insulin action in obese African-American and Latino adolescents J Clin Endocrinol Metab 95 2010 4048 4051
20. S.M. Haffner, G. Howard, and E. Mayer Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study Diabetes 46 1997 63 69 (Pubitemid 27009951)
21. A.J. Karter, E.J. Mayer-Davis, and J.V. Selby Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women The Insulin Resistance and Atherosclerosis Study Diabetes 45 1996 1547 1555 (Pubitemid 26357548)
22. S.M. Haffner, R. D'Agostino, and M.F. Saad Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites The Insulin Resistance Atherosclerosis Study Diabetes 45 1996 742 748
23. S.M. Petak, H.R. Nankin, R.F. Spark, R.S. Swerdloff, L.J. Rodriguez-Rigau American Association of Clinical Endocrinologists American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients2002 update Endocr Pract 8 2002 440 456
24. S. Bhasin, G.R. Cunningham, and F.J. Hayes Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 91 2006 1995 2010 (Pubitemid 43854972)
25. S.M. Harman, E.J. Metter, J.D. Tobin, J. Pearson, and M.R. Blackman Longitudinal effects of aging on serum total and free testosterone levels in healthy men J Clin Endocrinol Metab 86 2001 724 731 (Pubitemid 32207487)
26. A. Gray, H.A. Feldman, J.B. McKinlay, and C. Longcope Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study J Clin Endocrinol Metab 73 1991 1016 1025 (Pubitemid 21901140)
27. T.G. Travison, A.B. Araujo, A.B. O'Donnell, V. Kupelian, and J.B. McKinlay A population-level decline in serum testosterone levels in American men J Clin Endocrinol Metab 92 2007 196 202 (Pubitemid 46075010)
28. A.M. Traish, A. Guay, R. Feeley, and F. Saad The dark side of testosterone deficiency: I Metabolic syndrome and erectile dysfunction J Androl 30 2009 10 22
29. A.M. Traish, F. Saad, and A. Guay The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance J Androl 30 2009 23 32
30. A.M. Traish, F. Saad, R.J. Feeley, and A. Guay The dark side of testosterone deficiency: III Cardiovascular disease J Androl 30 2009 477 494
31. A.E. Hak, J.C.M. Witteman, F.H. de Jong, M.I. Geerlings, A. Hofman, and H.A.P. Pols Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam Study J Clin Endocrinol Metab 87 2002 3632 3639 (Pubitemid 34879505)
32. G. Phillips, B. Pinkernell, and T. Jing The association of hypotestosteronemia with coronary artery disease in men Arterioscler Thromb 14 1994 701 706
33. U. Srinivas-Shankar, S.A. Roberts, and M.J. Connolly Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study J Clin Endocrinol Metab 95 2010 639 650
34. I. van Pottelbergh, L. Braeckman, D. De Bacquer, G. De Backer, and J. Kaufman Potential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men Atherosclerosis 166 2003 95 102 (Pubitemid 35449605)
35. J.I. Makinen, A. Perheentupa, and K. Irjala Endogenous testosterone and serum lipids in middle-aged men Atherosclerosis 197 2008 688 693 (Pubitemid 351417865)
36. J. Makinen, M. Jarvisalo, and P. Pollanen Increased carotid atherosclerosis in andropausal middle-aged men J Am Coll Cardiol 45 2005 1603 1608 (Pubitemid 40704493)
37. D. Simon, M.A. Charles, and K. Nahoul Association between plasma testosterone and cardiovascular risk factors in healthy adult men: the Telecom study J Clin Endocrinol Metab 82 1997 682 685 (Pubitemid 27068651)
38. C.A. Allan, B.J. Strauss, H.G. Burger, E.A. Forbes, and R.I. McLachlan Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men J Clin Endocrinol Metab 93 2008 139 146
39. D. Kapoor, E. Goodwin, K.S. Channer, and T.H. Jones Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes Eur J Endocrinol 154 2006 899 1006
40. S. Basaria, D.C. Muller, M.A. Carducci, J. Egan, and A.S. Dobs Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy Cancer 106 2006 581 588 (Pubitemid 43157621)
41. A. Haidar, A. Yassin, F. Saad, and R. Shabsigh Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes Aging Male 10 2007 189 196 (Pubitemid 350146723)
42. M.A. Yialamas, A.A. Dwyer, E. Hanley, H. Lee, N. Pitteloud, and F.J. Hayes Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism J Clin Endocrinol Metab 92 2007 4254 4259 (Pubitemid 350074740)
43. B.B. Yeap, S.A. Chubb, and Z. Hyde Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health in Men Study Eur J Endocrinol 161 2009 591 598
44. R.K. Stellato, H.A. Feldman, O. Hamdy, E.S. Horton, and J.B. McKinlay Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study Diabetes Care 23 2000 490 494 (Pubitemid 30185792)
45. E. Selvin, M. Feinleib, and L. Zhang Androgens and diabetes in men Diabetes Care 30 2007 234 238
46. N. Pitteloud, M. Hardin, and A.A. Dwyer Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men J Clin Endocrinol Metab 90 2005 2636 2641 (Pubitemid 40686302)
47. N. Pitteloud, V.K. Mootha, and A.A. Dwyer Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men Diabetes Care 28 2005 1636 1642 (Pubitemid 41340902)
48. J.Y. Oh, E. Barrett-Connor, N.M. Wedick, D.L. Wingard Rancho Bernardo Study Endogenous sex hormones and the development of type 2 diabetes in older men and women; the Rancho Bernardo study Diabetes Care 25 2002 55 60 (Pubitemid 41070783)
49. A.M. Traish, R.J. Feeley, and A. Guay Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction FEBS J 276 2009 5755 5767
50. M. Fukui, Y. Kitagawa, H. Ose, G. Hasegawa, T. Yoshikawa, and N. Nakamura Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes Curr Diabetes Rev 3 2007 25 31 (Pubitemid 46592791)
51. M. Akishita, M. Hashimoto, and Y. Ohike Low testosterone level is an independent determinant of endothelial dysfunction in men Hypertens Res 30 2007 1029 1034
52. M. Akishita, M. Hashimoto, and Y. Ohike Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors Atherosclerosis 210 2009 232 236
53. C.J. Malkin, P.J. Pugh, R.D. Jones, D. Kapoor, K.S. Channer, and T.H. Jones The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men J Clin Endocrinol Metab 89 2004 3313 3318 (Pubitemid 38951897)
54. J.E. Nettleship, P.J. Pugh, K.S. Channer, T. Jones, and R.D. Jones Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease Horm Metab Res 39 2007 366 371 (Pubitemid 46877853)
55. A.M. Traish, R. Abdou, and K.E. Kypreos Androgen deficiency and atherosclerosis: the lipid link Vascul Pharmacol 51 2009 303 313
56. G. Caminiti, M. Volterrani, and F. Iellamo Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study J Am Coll Cardiol 54 2009 919 927
57. S. Basaria, A.D. Coviello, and T.G. Travison Adverse events associated with testosterone administration N Engl J Med 363 2010 109 122
58. M.M. Shores, A.M. Matsumoto, K.L. Sloan, and D.R. Kivlahan Low serum testosterone and mortality in male veterans Arch Intern Med 166 2006 1660 1665 (Pubitemid 44232378)
59. K.-T. Khaw, M. Dowsett, and E. Folkerd Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study Circulation 116 2007 2694 2701 (Pubitemid 350291241)
60. G.A. Laughlin, E. Barrett-Connor, and J. Bergstrom Low serum testosterone and mortality in older men J Clin Endocrinol Metab 93 2008 68 75
61. S. Bhasin, G.R. Cunningham, and F.J. Hayes Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline J Clin Endocrinol Metab 95 2010 2536 2559
62. M.M. Fernández-Balsells, M.H. Murad, and M. Lane Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis J Clin Endocrinol Metab 95 2010 2560 2575
63. C. Lorenzo, K. Williams, K.J. Hunt, and S.M. Haffner The National Cholesterol Education programAdult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes Diabetes Care 30 2007 8 13 (Pubitemid 46052493)
64. K. Esposito, F. Giugliano, and E. Martedi High proportions of erectile dysfunction in men with metabolic syndrome Diabetes Care 28 2005 1201 1203 (Pubitemid 40616635)
65. J.A. Osuna, R. Gómez-Pérez, G. Arata-Bellabarba, and V. Villaroel Relationship between BMI, total testosterone, sex hormone-binding- globulin, leptin, insulin and insulin resistance in obese men Arch Androl 52 2006 355 361 (Pubitemid 44174454)
66. M.J. Guembe, E. Toledo, and J. Barba Association between metabolic syndrome or its components and asymptomatic cardiovascular disease in the RIVANA-study Atherosclerosis 211 2010 612 617
67. C.J. Hobbs, S.R. Plymate, C.J. Rosen, and R.A. Adler Testosterone administration increases insulin-like growth factor-I levels in normal men J Clin Endocrinol Metab 77 1993 776 779 (Pubitemid 23298665)
68. R. Singh, J.N. Artaza, and W.E. Taylor Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors Endocrinology 147 2006 141 154 (Pubitemid 43004269)
69. S.Y. Kalinchenko, Y.A. Tishova, G.J. Mskhalaya, L.J. Gooren, E.J. Giltay, and F. Saad Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study Clin Endocrinol (Oxf) 73 2010 602 612
70. A. Aversa, R. Bruzziches, D. Francomano, and G. Spera Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome J Endocrinol Invest 33 2010 776 783
71. A. Aversa, R. Bruzziches, D. Francomano, G. Rosano, A. Lenzi, and G. Spera Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late onset hypogonadism and metabolic syndrome: results from a 24-months, randomized double blind placebo-controlled study J Sex Med 7 2010 3495 3503
72. S. La Vignera, A.E. Calogero, and R. D'Agata Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism Minerva Endocrinol 33 2008 159 167
73. R.D. Stanworth, D. Kapoor, K.S. Channer, and T.H. Jones Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes Diabetes Care 32 2009 541 546
74. D. Kapoor, K.S. Channer, and T.H. Jones Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes Diab Vasc Dis Res 5 2 2008 135 137 (Pubitemid 351839286)
75. G. Corona, and M. Maggi The role of testosterone in erectile dysfunction Nat Rev Urol 7 2010 46 56
76. J. Svartberg, U. Aasebo, A. Hjalmarsen, J. Sundsfjord, and R. Jorde Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial Resp Med 98 2004 906 913 (Pubitemid 39069342)
77. R.A. Anderson, J. Bancroft, and F.C. Wu The effects of exogenous testosterone on sexuality and mood of normal men J Clin Endocrinol Metab 75 1992 1503 1507 (Pubitemid 23001411)
78. A. Aversa, A.M. Isidori, G. Spera, A. Lenzi, and A. Fabbri Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction Clin Endocrinol 58 2003 632 638 (Pubitemid 36566807)
79. O. Benkert, W. Witt, W. Adam, and A. Leitz Effects of testosterone undecanoate on sexual potency and the hypothalamic-pituitary-gonadal axis of impotent males Arch Sex Behav 8 1979 471 479 (Pubitemid 11197126)
80. G. Cavallini, S. Caracciolo, G. Vitali, F. Modenini, and G. Biagiotti Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging Urology 63 2004 641 646 (Pubitemid 38479399)
81. P. Kunelius, O. Lukkarinen, M.L. Hannuksela, O. Itkonen, and J.S. Tapanainen The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study J Clin Endocrinol Metab 87 2002 1467 1472 (Pubitemid 34615223)
82. N.C. Park, B.Q. Yan, J.M. Chung, and K.M. Lee Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency Aging Male 6 2003 86 93 (Pubitemid 36936510)
83. R.C. Schiavi, D. White, J. Mandeli, and A.C. Levine Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction Arch Sex Behav 26 1997 231 241 (Pubitemid 27188130)
84. R. Shabsigh, J.M. Kaufman, C. Steidle, and H. Padma-Nathan Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone J Urol 172 2004 658 663 (Pubitemid 38900229)
85. R. Shabsigh Testosterone therapy in erectile dysfunction and hypogonadism J Sex Med 2 2005 785 792 (Pubitemid 41727391)
86. E.R. Bolona, M.V. Uraga, and R.M. Haddad Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials Mayo Clin Proc 82 1 2007 20 28 (Pubitemid 46036318)
87. A.M. Isidori, E. Giannetta, and D. Gianfrilli Effects of testosterone on sexual function in men: results of a meta-analysis Clin Endocrinol (Oxf) 63 2005 381 394 (Pubitemid 41442332)
88. M.M. Miner, and L. Kuritzky Erectile dysfunction: a sentinel marker for cardiovascular disease in primary care Cleve Clin J Med 74 Suppl 3 2007 S30 S37
89. O. Yildiz, and M. Seyrek Vasodilating mechanisms of testosterone Exp Clin Endocrinol Diabetes 115 2007 1 6 (Pubitemid 46293403)
90. M. Seyrek, O. Yildiz, H.B. Ulusoy, and V. Yildirim Testosterone relaxes isolated human radial artery by potassium channel opening action J Pharmacol Sci 103 2007 309 316 (Pubitemid 46465774)
91. K.M. Lakshman, and S. Basaria Safety and efficacy of testosterone gel in the treatment of male hypogonadism Clin Interv Aging 4 2009 397 412
92. M. Zitzmann, and E. Nieschlag Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men J Clin Endocrinol Metab 92 2007 3844 3853 (Pubitemid 47607632)
93. F. Saad, L.J. Gooren, A. Haider, and A. Yassin A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate J Androl 29 2008 102 105
94. F.C.W. Wu, A. Tajar, and J. Beynon Identification of late-onset hypogonadism in middle-aged and elderly men N Engl J Med 363 2010 123 135
95. M. Zitzmann Testosterone deficiency and treatment in older men: definition, treatment, pitfalls Asian J Androl 12 2010 623 625
96. L.J. Gooren, H.M. Behre, F. Saad, A. Frank, and S. Schwerdt Diagnosing and treating testosterone deficiency in different parts of the world Results from global market research Aging Male 10 2007 173 181 (Pubitemid 350146724)
97. Endogenous Hormones and Prostate Cancer Collaborative Group Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies J Natl Cancer Inst 100 2008 170 183
98. W.R. Carpenter, R.R. Whitney, and P.A. Godley Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer [Editorial] J Natl Cancer Inst 100 2008 158 159 (Pubitemid 351480558)
99. O.M. Calof, A.B. Singh, and M.L. Lee Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials J Gerontol A Biol Sci Med Sci 60 2005 1451 1457 (Pubitemid 41798454)
100. A. Morgentaler, and A.M. Traish Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth Eur Urol 55 2009 310 320
101. C. Wang, E. Nieschlag, and R.S. Swerdloff ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males Aging Male 12 2009 5 12
102. E. Nieschlag, R. Swerdloff, and H.M. Behre International Society of Andrology (ISA); International Society for the Study of the Aging Male (ISSAM); European Association of Urology (EAU) Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations Eur Urol 48 2005 1 4
103. E. Nieschlag, R. Swerdloff, and H.M. Behre Investigation, treatment and monitoring of late-onset hypogonadism in males Aging Male 8 2005 56 58 (Pubitemid 40978894)
104. E. Nieschlag, R. Swerdloff, and H.M. Behre Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations Int J Androl 28 2005 125 127 (Pubitemid 40780337)
105. C. Wang, E. Nieschlag, and R. Swerdloff Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations J Androl 30 2009 1 9
106. C. Wang, E. Nieschlag, and R. Swerdloff ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males Int J Impot Res 21 2009 1 8
107. M. Kazi, S.A. Geraci, and C.A. Koch Considerations for the diagnosis and treatment of testosterone deficiency in elderly men Am J Med 120 2007 835 840 (Pubitemid 47451287)
108. B.D. Anawalt Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal J Clin Endocrinol Metab 95 2010 2614 2617
109. R.I. McLachlan Certainly more guidelines than rules J Clin Endocrinol Metab 95 2010 2610 2613
110. F. Jockenhvel, T. Minnemann, and M. Schubert Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood Aging Male 12 2009 113 118
111. A. Morgentaler Commentary: guideline for male testosterone therapy: a clinician's perspective J Clin Endocrinol Metab 92 2007 416 417
112. S. Moreno, A. Shyam, and A. Morgentaler Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population J Sex Med 7 2010 1948 1953